Compare HALO & WFRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HALO | WFRD |
|---|---|---|
| Founded | 1998 | 1941 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.8B | 7.8B |
| IPO Year | 2001 | 2014 |
| Metric | HALO | WFRD |
|---|---|---|
| Price | $68.88 | $108.75 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 9 |
| Target Price | $78.64 | ★ $103.22 |
| AVG Volume (30 Days) | ★ 1.5M | 1.0M |
| Earning Date | 05-05-2026 | 04-21-2026 |
| Dividend Yield | N/A | ★ 1.03% |
| EPS Growth | N/A | ★ N/A |
| EPS | 1.22 | ★ 1.49 |
| Revenue | $151,862,000.00 | ★ $4,331,000,000.00 |
| Revenue This Year | $28.24 | N/A |
| Revenue Next Year | $12.56 | $5.22 |
| P/E Ratio | ★ $55.91 | $72.77 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $51.06 | $42.75 |
| 52 Week High | $82.22 | $113.15 |
| Indicator | HALO | WFRD |
|---|---|---|
| Relative Strength Index (RSI) | 56.11 | 54.84 |
| Support Level | $67.94 | $101.35 |
| Resistance Level | $69.95 | $112.01 |
| Average True Range (ATR) | 2.58 | 3.67 |
| MACD | 0.17 | -0.22 |
| Stochastic Oscillator | 51.49 | 61.27 |
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.
Weatherford provides oilfield services and equipment to national, integrated, public, and private oil and gas operators. It operates across multiple upstream markets, including offshore, the rest of the world onshore, and US onshore, where Weatherford has limited exposure. The Middle East, North Africa, and Asia account for over 25% of sales. Weatherford also offers manufacturing, research, and training services. Performance is reported through three segments: drilling and evaluation, well construction and completions, and production and intervention.